Announcement on Change of Accounting Policies
Filed with SSE · · 2 pages · Chinese
Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Earlier from Vcanbio Cell & Gene Engineering
- Announcement on Returning Idle Raised Funds Used for Temporarily Supplementing Current Capital
- Announcement on the Resignation of Deputy General Manager and Secretary of the Board of Directors
- Announcement on Returning Idle Raised Funds for Cash Management to Special Account for Raised Funds
- Announcement on Signing Property Service Entrustment Contract and Related Transactions between Holding Subsidiaries and Tianjin Hongkan Property Operation Management Co., Ltd.
- Announcement on Obtaining Notice of Acceptance for Drug Clinical Trial Application of the Wholly-owned Subsidiary
Later from Vcanbio Cell & Gene Engineering
- Announcement on Convening the 2024 Annual Performance Briefing
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Resolution of the 9th Extraordinary Meeting of the 11th Board of Supervisors
- Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial
- Announcement on Returning Idle Raised Funds Used for Cash Management to Special Account for Raised Funds
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering